MedInsights works on disease/drug landscaping, drug de-risking pipeline, biomarker identification and validation (preclinical evidence generation through collaborations) and drug target in silico analysis for rare and oncology indications. We are looking for potential partners in industry and academia to expand our capabilities, investment opportunities from VC funds for platform expansion and research activities and funding opportunities (academic grants in collaboration).